Market Cap 3.37B
Revenue (ttm) 560.23M
Net Income (ttm) -569.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.60%
Debt to Equity Ratio 0.00
Volume 966,100
Avg Vol 858,892
Day's Range N/A - N/A
Shares Out 93.89M
Stochastic %K 92%
Beta 0.61
Analysts Strong Sell
Price Target $93.21

Latest News on RARE

Ultragenyx: Commercial Engine Fuels Rare Disease Pipeline

Apr 16, 2025, 9:49 AM EDT - 7 days ago

Ultragenyx: Commercial Engine Fuels Rare Disease Pipeline


Ultragenyx to Participate at Investor Conferences in March

Feb 24, 2025, 4:30 PM EST - 2 months ago

Ultragenyx to Participate at Investor Conferences in March


Ultragenyx to Participate in Investor Conferences in December

Nov 26, 2024, 4:30 PM EST - 5 months ago

Ultragenyx to Participate in Investor Conferences in December


Ultragenyx: Ready For More Growth After Q3 Earnings Beat

Nov 12, 2024, 11:12 AM EST - 5 months ago

Ultragenyx: Ready For More Growth After Q3 Earnings Beat


Ultragenyx to Participate in Investor Conferences in September

Aug 29, 2024, 4:30 PM EDT - 8 months ago

Ultragenyx to Participate in Investor Conferences in September